Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2013-09-19 14:14:55
Reporting Period:
Filing Date:
Accepted Time:
2013-09-19 14:14:55
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
875045 Biogen Idec Inc. BIIB Biological Products, (No Disgnostic Substances) (2836) 330112644
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1409601 J Paul Clancy Biogen Idec Inc.
133 Boston Post Road
Weston MA 02493
Executive Vp And Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-09-18 26,785 $49.65 33,872 No 4 M Direct
Common Stock Disposition 2013-09-18 26,785 $245.00 7,087 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2013-09-18 26,785 $0.00 26,785 $49.65
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2019-02-24 No 4 M Direct
  1. Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
  2. The stock options become exercisable in four (4) equal annual installments commencing one year after the grant date of 02/24/09.